Romain Cazavan from Medexprim explains the nature of our partnership with Sophia Genetics and how we contribute to providing cleaned data to advance discoveries to fight cancer.
Sword and Medexprim : combining clinical and imaging data in big-data research projects
Sword Group and Medexprim are partnering in view to offer cancer centers and large hospitals a unified solution to facilitate translational research, combining clinical and imaging data.
